• user warning: Table './fnndrupaldev/term_node' is marked as crashed and last (automatic?) repair failed query: SELECT t.* FROM term_node r INNER JOIN term_data t ON r.tid = t.tid INNER JOIN vocabulary v ON t.vid = v.vid WHERE r.vid = 459719 ORDER BY v.weight, t.weight, t.name in /var/www/www.fnno.com/htdocs/modules/taxonomy/taxonomy.module on line 617.
  • user warning: Table './fnndrupaldev/sessions' is marked as crashed and last (automatic?) repair failed query: SELECT COUNT(sid) AS count FROM sessions WHERE timestamp >= 1413990919 AND uid = 0 in /var/www/www.fnno.com/htdocs/includes/session.inc on line 111.
  • user warning: Table './fnndrupaldev/sessions' is marked as crashed and last (automatic?) repair failed query: SELECT DISTINCT u.uid, u.name, s.timestamp FROM users u INNER JOIN sessions s ON u.uid = s.uid WHERE s.timestamp >= 1413990919 AND s.uid > 0 ORDER BY s.timestamp DESC in /var/www/www.fnno.com/htdocs/modules/user/user.module on line 765.

Stock Investors Bid Up Shares of Celldex Therapeutics, Up 1.4%

Published on Thu, 03/14/2013 - 12:46
By Mallory Stone

One of today's notable stocks on the rise is Celldex Therapeutics (NASDAQ:CLDX), up 1.4% to $12.00. The Dow is up 0.4% to 14,518 and the S&P is currently up 0.4% to 1,561.

In the past 52 weeks, shares of Celldex Therapeutics have traded between a low of $3.82 and a high of $12.49 and are now at $12.00, which is 214% above that low price. Over the past week, the 200-day moving average (MA) has gone up 1.9% while the 50-day MA has advanced 3.9%.

Celldex Therapeutics Inc., a biopharmaceutical company, uses applications of immunology to prevent and treat diseases. The Company's products treat autoimmune diseases, cardiovascular diseases, cancer, and inflammation, as well as infectious diseases and organ transplant rejection.

Based on a current price of $12.00, Celldex Therapeutics is currently 0.0% above its average consensus analyst price target of $12.00. The stock should discover initial support at its 50-day moving average (MA) of $8.39 and subsequent support at its 200-day MA of $6.21.

By Mallory Stone
mstone@fnno.com

Latest News from FNNO

Stock to Watch: Nanosphere Down 36.7% (N...

Nanosphere (NASDAQ:NSPH) is one of today's worst performing penny stocks, down 36.7% to ...

Next Resistance Level for SCANA (SCG) is...

Shares of SCANA (NYSE:SCG) have bullishly opened above the pivot of $52.31 today and ha ...

Watch for Shares of Chubb (CB) to Approa...

Shares of Chubb (NYSE:CB) have bullishly opened above the pivot of $93.63 today and hav ...

Iron Mountain (IRM) Breaks Through Resis...

Shares of Iron Mountain (NYSE:IRM) opened today above their pivot of $33.90 and have al ...

Republic Services (RSG) Crosses Pivot Po...

Republic Services (NYSE:RSG) has opened bullishly above the pivot of $38.60 today and h ...

Watch for Shares of People's United Fina...

People's United Financial (NASDAQ:PBCT) has opened bullishly above the pivot of $14.15 ...

Ryder System (R) Breaks Through Support ...

Shares of Ryder System (NYSE:R) have bearishly opened below the pivot of $86.21 today a ...

Coach (COH) Breaks Through Resistance at...

Coach (NYSE:COH) has opened bullishly above the pivot of $35.38 today and has reached t ...